New CRO partner: Pharmaron
Published: October 23, 2026
1 minute read
Authored by: Jens Gertow
We are pleased to welcome Pharmaron as a new CRO partner. Pharmaron is an integrated CRO and CDMO supporting cell and gene therapy development from early discovery through to commercialization. This partnership brings Mabtech's ELISpot and FluoroSpot assays, analyzed on the IRIS 2 reader, into Pharmaron’s development workflows, giving joint customers sensitive immune monitoring at every stage of a program.
Pharmaron’s end-to-end capabilities include preclinical studies, bioanalysis, analytical testing, regulatory support, and cGMP manufacturing for AAV, viral and non-viral gene therapies as well as cell-based therapeutics. Mabtech's single-cell functional readouts fit naturally into this offering and help developers characterize immune responses to novel therapies with confidence.
Together, Mabtech and Pharmaron aim to help cell and gene therapy innovators move their candidates from concept into the clinic more quickly, with immune monitoring built on validated, high-sensitivity methods.
